BET Bromodomain Inhibitors Enhance Efficacy and Disrupt Resistance to AR Antagonists in the Treatment of Prostate Cancer.

Molecular Cancer Research : MCR
Irfan A AsanganiArul M Chinnaiyan

Abstract

Next-generation antiandrogen therapies, such as enzalutamide and abiraterone, have had a profound impact on the management of metastatic castration-resistant prostate cancer (mCRPC). However, mCRPC patients invariably develop resistance to these agents. Here, a series of clonal cell lines were developed from enzalutamide-resistant prostate tumor xenografts to study the molecular mechanism of resistance and test their oncogenic potential under various treatment conditions. Androgen receptor (AR) signaling was maintained in these cell lines, which acquired potential resistance mechanisms, including expression of AR-variant 7 (AR-v7) and glucocorticoid receptor. BET bromodomain inhibitors were shown previously to attenuate AR signaling in mCRPC; here, we demonstrate the efficacy of bromodomain and extraterminal (BET) inhibitors in enzalutamide-resistant prostate cancer models. AR antagonists, enzalutamide, and ARN509 exhibit enhanced prostate tumor growth inhibition when combined with BET inhibitors, JQ1 and OTX015, respectively. Taken together, these data provide a compelling preclinical rationale to combine BET inhibitors with AR antagonists to subvert resistance mechanisms. Therapeutic combinations of BET inhibitors and AR anta...Continue Reading

References

Jan 2, 2004·Nature Medicine·Charlie D ChenCharles L Sawyers
Sep 28, 2010·Nature·Panagis FilippakopoulosJames E Bradner
May 27, 2011·The New England Journal of Medicine·Johann S de BonoUNKNOWN COU-AA-301 Investigators
Sep 6, 2011·Cell·Jake E DelmoreConstantine S Mitsiades
Jan 24, 2012·Cancer Research·Nicola J CleggJeffrey H Hager
Aug 17, 2012·The New England Journal of Medicine·Howard I ScherUNKNOWN AFFIRM Investigators
Sep 5, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dana E RathkopfHoward I Scher
Sep 4, 2014·The New England Journal of Medicine·Emmanuel S AntonarakisJun Luo
May 23, 2015·Cell·Dan RobinsonArul M Chinnaiyan

❮ Previous
Next ❯

Citations

Apr 5, 2016·Medical Oncology·Laura Graham, Michael T Schweizer
Jun 4, 2016·International Journal of Urology : Official Journal of the Japanese Urological Association·Alan H Bryce, Emmanuel S Antonarakis
Oct 23, 2016·Drug Discovery Today. Technologies·Ester Fernandez-SalasArul M Chinnaiyan
Aug 6, 2016·Cellular and Molecular Life Sciences : CMLS·Dequina A NicholasGerald V Denis
Sep 7, 2016·Bulletin du cancer·Nicolas Penel
Sep 22, 2016·Clinical Epigenetics·Inês GraçaCarmen Jerónimo
Nov 2, 2016·Endocrine-related Cancer·Isabel CoutinhoLuke A Selth
Dec 18, 2016·International Urology and Nephrology·Jieping Hu, Qingke Chen
Jun 19, 2017·Molecular and Cellular Endocrinology·Alfonso Urbanucci, Ian G Mills
Feb 27, 2017·Molecular & Cellular Proteomics : MCP·Kyle C ArendNathaniel J Moorman
Jan 20, 2017·ELife·Fraser AirdUNKNOWN Reproducibility Project: Cancer Biology
Jul 18, 2017·Expert Opinion on Drug Discovery·Georg Karpel-MasslerMarkus D Siegelin
May 10, 2017·International Journal of Molecular Sciences·Simon J Baumgart, Bernard Haendler
Apr 7, 2018·Expert Opinion on Drug Discovery·Achuta Kumar Guddati
Oct 17, 2017·Expert Opinion on Investigational Drugs·Mark C MarkowskiEmmanuel S Antonarakis
Dec 8, 2017·Current Molecular Biology Reports·Zoran Culig
Dec 23, 2017·Scientific Reports·Kati KivinummiTapio Visakorpi
Aug 16, 2017·Endocrine-related Cancer·Takuma UoCynthia C Sprenger
Jan 13, 2017·Microbiology and Molecular Biology Reviews : MMBR·Victoria JeffersWilliam J Sullivan
Oct 20, 2018·The Journal of Clinical Investigation·Adam SharpStephen R Plymate
Feb 20, 2019·Endocrine-related Cancer·Peder Rustøen Braadland, Alfonso Urbanucci
Nov 2, 2018·Endocrine-related Cancer·Simon LinderStefan Prekovic
Mar 21, 2019·Current Opinion in Oncology·David J EinsteinSteven P Balk
Jan 10, 2018·Cold Spring Harbor Perspectives in Medicine·Aaron M Udager, Scott A Tomlins
Feb 9, 2018·Expert Opinion on Therapeutic Targets·Takuma UoCynthia C Sprenger
Oct 2, 2019·Nature Reviews. Clinical Oncology·Daphné MorelSophie Postel-Vinay
Jun 11, 2016·Oncotarget·Vaibhav SahaiHidayatullah G Munshi
Sep 26, 2019·Scientific Reports·Florian HandleFrank Claessens
Apr 30, 2017·Nature Reviews. Cancer·Gina M SizemoreMichael C Ostrowski
Sep 6, 2018·Genes & Development·Guocan WangRonald A DePinho
Mar 8, 2019·Nature Medicine·Helai P MohammadCaretha L Creasy
May 18, 2016·Journal of Cellular Physiology·Samantha M MillerGary L Johnson
Sep 12, 2018·Diagnostics·Arlou Kristina AngelesHolger Sültmann
Jun 24, 2018·World Journal of Urology·Marie C HupeMarcus V Cronauer
Jun 19, 2018·Frontiers in Oncology·Alexandra Vander ArkXiaohong Li
May 31, 2019·Frontiers in Oncology·Gianluca CivenniCarlo V Catapano
Apr 9, 2017·Cold Spring Harbor Perspectives in Medicine·Charles DaiNima Sharifi
Aug 24, 2018·Nature Reviews. Clinical Oncology·Alec PaschalisJohann S de Bono
Apr 19, 2018·Proceedings of the National Academy of Sciences of the United States of America·Leigh Ellis, Massimo Loda
May 8, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeremy LewinChristophe Massard
Jun 12, 2018·Current Molecular Biology Reports·Katia RuggeroAlvaro Aytes
Mar 8, 2019·Endocrine-related Cancer·Peder Rustøen Braadland, Alfonso Urbanucci

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.